Metaphedrone (3-Methylmethcathinone): Pharmacological, Clinical, and Toxicological Profile

Overview

Journal Medicina (Kaunas)

Publisher MDPI

Specialty General Medicine

Date 2024 Mar 28

PMID 38541192

Authors

Igor Kelecevic

Ana-Marija Vejnovic

Jovan Javorac

Nemanja Gvozdenovic

Natasa Janjic

Vesna Mijatovic Jovin

Affiliations

Soon will be listed here.

Abstract

Synthetic cathinones are a group of novel psychoactive substances used as an alternative to classical recreational drugs. As a result of legal prohibitions on older generations of these compounds, new formulations appeared on the drug market. One of them is metaphedrone (3-methylmethcathinone, 3-MMC), a structural isomer of 4-methylmethcathinone and a psychostimulant drug. Metaphedrone became popular in a large number of countries in a short period of time. The collection, analysis, and review of relevant research on the subject of metaphedrone in order to present information about the pharmacological, clinical, and toxicological profile of this compound. An assessment of the significance and role of metaphedrone in consumption patterns of novel psychoactive substances among recreational drug users. By using search engines like Google Scholar and PubMed, the relevant literature on metaphedrone was looked for and analyzed. The search was not limited to a specific period of time. All information regarding the compound of interest was analyzed and presented. All novel psychoactive substances are abused due to their pronounced stimulatory, hallucinogenic, dissociative, and euphoric and/or relaxing characteristics. Users of 3-methylmethcathinone usually opt for this substance for recreational purposes and/or sexual stimulation. Metaphedrone has the potential to cause a psychological dependence to the users. It was determined in relevant studies that most users are from 17 to 50 years of age. Older users usually administer metaphedrone intravenously, while younger ones usually choose snorting and oral ingestion of the drug. In Serbia, metaphedrone is a legally controlled substance. The pharmacodynamic properties make metaphedrone similar to classical recreational drugs. The method of administration, mainly repeated administration in a single session, could be explained using the pharmacokinetic profile of the drug. The most reported symptoms of intoxication were those of a sympathomimetic nature, such as tachycardia, chest pain, hypertension, diaphoresis, and agitation. Most intoxications and fatal outcomes occurred to users who combined several psychoactive substances. The correlation between measured blood concentrations of the drug and outcomes of intoxication was not found. The mechanisms of metaphedrone's toxicity are not fully understood. There is an increasing trend of abuse of metaphedrone among recreational drugs users. Future studies should focus on pharmacological and toxicological effects of metaphedrone on animals and humans.

Citing Articles

Comprehensive evaluation of the toxicological effects of commonly encountered synthetic cathinones using in silico methods.

Yalcin C, Sarialtin S, Raitano G, Benfenati E Toxicol Res (Camb). 2025; 14(1):tfaf012.

PMID: 39850661 PMC: 11751583. DOI: 10.1093/toxres/tfaf012.

The Search for the Optimal Methodology for Predicting Fluorinated Cathinone Drugs NMR Chemical Shifts.

Makieieva N, Kupka T, Rahmonov O Molecules. 2025; 30(1.

PMID: 39795111 PMC: 11721958. DOI: 10.3390/molecules30010054.

References

Guner R, Hasanoglu I, Aktas F . COVID-19: Prevention and control measures in community. Turk J Med Sci. 2020; 50(SI-1):571-577. PMC: 7195988. DOI: 10.3906/sag-2004-146. View

Spiller H, Ryan M, Weston R, Jansen J . Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States. Clin Toxicol (Phila). 2011; 49(6):499-505. DOI: 10.3109/15563650.2011.590812. View

Adamowicz P, Gieron J, Gil D, Lechowicz W, Skulska A, Tokarczyk B . 3-Methylmethcathinone--Interpretation of Blood Concentrations Based on Analysis of 95 Cases. J Anal Toxicol. 2016; 40(4):272-6. DOI: 10.1093/jat/bkw018. View

Ameline A, Dumestre-Toulet V, Raul J, Kintz P . Determination of a threshold fatal 3-MMC concentration in human: mission impossible. Psychopharmacology (Berl). 2018; 236(3):865-867. DOI: 10.1007/s00213-018-4941-5. View

Henry J, Jeffreys K, Dawling S . Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy"). Lancet. 1992; 340(8816):384-7. DOI: 10.1016/0140-6736(92)91469-o. View

Institoris L, Arok Z, Seprenyi K, Varga T, Sara-Klausz G, Keller E . Frequency and structure of stimulant designer drug consumption among suspected drug users in Budapest and South-East Hungary in 2012-2013. Forensic Sci Int. 2015; 248:181-6. DOI: 10.1016/j.forsciint.2015.01.002. View

Szendrei K . The chemistry of khat. Bull Narc. 1980; 32(3):5-35. View

Vincenti F, Gregori A, Flammini M, Di Rosa F, Salomone A . Seizures of New Psychoactive Substances on the Italian territory during the COVID-19 pandemic. Forensic Sci Int. 2021; 326:110904. PMC: 8411784. DOI: 10.1016/j.forsciint.2021.110904. View

Ledberg A . The interest in eight new psychoactive substances before and after scheduling. Drug Alcohol Depend. 2015; 152:73-8. DOI: 10.1016/j.drugalcdep.2015.04.020. View

10.

Coppola M, Mondola R . Synthetic cathinones: chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as "bath salts" or "plant food". Toxicol Lett. 2012; 211(2):144-9. DOI: 10.1016/j.toxlet.2012.03.009. View

11.

Drevin G, Rossi L, Ferec S, Briet M, Abbara C . Chemsex/slamsex-related intoxications: A case report involving gamma-hydroxybutyrate (GHB) and 3-methylmethcathinone (3-MMC) and a review of the literature. Forensic Sci Int. 2021; 321:110743. DOI: 10.1016/j.forsciint.2021.110743. View

12.

Ahmed S, Zhou Z, Zhou J, Chen S . Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine. Genomics Proteomics Bioinformatics. 2016; 14(5):298-313. PMC: 5093856. DOI: 10.1016/j.gpb.2016.03.008. View

13.

De Boer A, Breimer D, Mattie H, Pronk J, Gubbens-Stibbe J . Rectal bioavailability of lidocaine in man: partial avoidance of "first-pass" metabolism. Clin Pharmacol Ther. 1979; 26(6):701-9. DOI: 10.1002/cpt1979266701. View

14.

Zawilska J . Mephedrone and other cathinones. Curr Opin Psychiatry. 2014; 27(4):256-62. DOI: 10.1097/YCO.0000000000000066. View

15.

Al-Maweri S, Warnakulasuriya S, Samran A . Khat (Catha edulis) and its oral health effects: An updated review. J Investig Clin Dent. 2017; 9(1). DOI: 10.1111/jicd.12288. View

16.

Nugteren-Van Lonkhuyzen J, Essink S, Rietjens S, Ohana D, de Lange D, van Riel A . 3-Methylmethcathinone (3-MMC) Poisonings: Acute Clinical Toxicity and Time Trend Between 2013 and 2021 in the Netherlands. Ann Emerg Med. 2022; 80(3):203-212. DOI: 10.1016/j.annemergmed.2022.04.022. View

17.

Frison G, Frasson S, Zancanaro F, Tedeschi G, Zamengo L . Detection of 3-methylmethcathinone and its metabolites 3-methylephedrine and 3-methylnorephedrine in pubic hair samples by liquid chromatography-high resolution/high accuracy Orbitrap mass spectrometry. Forensic Sci Int. 2016; 265:131-7. DOI: 10.1016/j.forsciint.2016.01.039. View

18.

Karinen R, Tuv S, Rogde S, Peres M, Johansen U, Frost J . Lethal poisonings with AH-7921 in combination with other substances. Forensic Sci Int. 2014; 244:e21-4. DOI: 10.1016/j.forsciint.2014.08.013. View

19.

Sande M . Characteristics of the use of 3-MMC and other new psychoactive drugs in Slovenia, and the perceived problems experienced by users. Int J Drug Policy. 2015; 27:65-73. DOI: 10.1016/j.drugpo.2015.03.005. View

20.

Paillet-Loilier M, Cesbron A, Le Boisselier R, Bourgine J, Debruyne D . Emerging drugs of abuse: current perspectives on substituted cathinones. Subst Abuse Rehabil. 2014; 5:37-52. PMC: 4043811. DOI: 10.2147/SAR.S37257. View